Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

165.36
-0.3000-0.18%
Post-market: 165.360.00000.00%19:59 EDT
Volume:6.50M
Turnover:1.08B
Market Cap:42.94B
PE:-11.63
High:167.13
Open:166.83
Low:165.11
Close:165.66
52wk High:176.60
52wk Low:133.73
Shares:259.67M
Float Shares:259.67M
Volume Ratio:0.83
T/O Rate:2.51%
Dividend:2.53
Dividend Rate:1.53%
EPS(TTM):-14.2170
EPS(LYR):-14.2170
ROE:-9.22%
ROA:1.03%
PB:1.25
PE(LYR):-11.63

Loading ...

Top Midday Stories: Stocks Fall, Oil Rises Amid Renewed Fighting in Middle East; Utility Shares Fall After California Wildfire Legislation

MT Newswires Live
·
Aug 31

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live
·
Aug 31

Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...

Dow Jones
·
Aug 31

Sunshine Lake Pharma Details Terms of New Healthcare-Focused Investment Fund

TIPRANKS
·
Aug 31

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Definium Therapeutics (DFTX) and IDEAYA Biosciences (IDYA)

TIPRANKS
·
Aug 31

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks

MT Newswires Live
·
Aug 31

Sector Update: Healthcare

MT Newswires Live
·
Aug 31

Sabra Healthcare REIT Price Target Raised to $23.00/Share from $21.00 by Barclays

Dow Jones
·
Aug 31

States Namenda Tablets not Withdrawn for Safety or Effectiveness Reasons - Federal Register

THOMSON REUTERS
·
Aug 31

FDA: Will not Begin Procedures to Withdraw Approval of Abbreviated New Drug Applications That Refer to Namenda Products - Federal Register

THOMSON REUTERS
·
Aug 31

Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.

Dow Jones
·
Aug 31

AbbVie to Present at Wells Fargo Healthcare Conference

Reuters
·
Aug 31

Kalaris to Present at Morgan Stanley 24th Annual Global Healthcare Conference

GlobeNewswire
·
Aug 31

Omega Healthcare is Maintained at Neutral by Mizuho

Dow Jones
·
Aug 31

Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results

Dow Jones
·
Aug 31

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.

Dow Jones
·
Aug 31

Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA

TIPRANKS
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31